2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)
Европейские рекомендации 2016 года по профилактике сердечно-сосудистых заболеваний в клинической практике
2016-06-27
SCID: 54.1/d2pnddpb
Discuss with AI
cardiovascular disease preventioncardiovascular risk factorsclinical practice guidelinescoronary artery diseasehealthy lifestyle promotion
Figures from the paper
Abstract (AI)
... ... Cardiovascular disease (CVD) prevention is defined as a coordinated set of actions, at the population level or targeted at an individual, that are aimed at eliminating or minimizing the impact of CVDs and their related disabilities.1 CVD remains a leading cause of morbidity and mortality, despite improvements in outcomes. Age-adjusted coronary artery disease (CAD) mortality has declined since the 1980s, particularly in high-income regions.2 CAD rates are now less than half what they were in the early 1980s in many countries in Europe, due to preventive measures including the success of smoking legislation. However, inequalities between countries persist and many risk factors, particularly obesity3 and diabetes mellitus (DM),4 have been increasing substantially. If prevention was practised as instructed it would markedly reduce the prevalence of CVD. It is thus not only prevailing risk factors that are of concern, but poor implementation of preventive measures as well.5,6 Prevention should be delivered (i) at the general population level by promoting healthy lifestyle behaviour7 and (ii) at the individual level, i.e. in those subjects at moderate to high risk of CVD or patients with established CVD, by tackling unhealthy lifestyles (e.g. poor-quality diet, physical inactivity, smoking) and by optimising risk factors. Prevention is effective: the elimination of health risk behaviours would make it possible to prevent at least 80% of CVDs and even 40% of cancers.8,9
Key Findings
1
Age-adjusted coronary artery disease mortality has declined since the 1980s, with rates below half of early-1980s levels in many European countries.
2
Cardiovascular disease prevention requires coordinated population-level and individual-level actions to reduce disease burden and disability.
3
Eliminating unhealthy risk behaviours could prevent at least 80% of cardiovascular diseases and 40% of cancers, but implementation of recommended prevention remains inadequate.
4
Obesity and diabetes mellitus are increasing substantially, highlighting continuing and emerging cardiovascular risk-factor challenges.
5
Smoking legislation and other preventive measures contributed substantially to declining coronary artery disease rates, although inequalities between European countries persist.
Research Object
Clinical practice guidelines for cardiovascular disease prevention in Europe (2016)
Research Subject
coordinated population- and individual-level actions to eliminate or minimize cardiovascular disease and related disabilities, including lifestyle modification and optimization of risk factors
Publication Details
Publication Date
2016-06-27
Journal
Publisher
ISSN
Cited by
1447
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai20
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations2008
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
Quantity and Quality of Exercise for Developing and Maintaining Cardiorespiratory, Musculoskeletal, and Neuromotor Fitness in Apparently Healthy Adults2011
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)2012
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation2015
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes2008
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 20122012
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines2004
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
Guidelines for the management of atrial fibrillation2010
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes2015
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet2013
European guidelines on cardiovascular disease prevention in clinical practice: executive summary2007
ESC/EAS Guidelines for the management of dyslipidaemias2011
Forecasting the Future of Cardiovascular Disease in the United States2011
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes2014
Nicotine replacement therapy for smoking cessation2012
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation2008
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2013
Exercise Standards for Testing and Training: A Statement for Healthcare Professionals From the American Heart Association2001